NCT04314011View on ClinicalTrials.gov

Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

December 30, 2021

Study Completion Date

March 1, 2022

Conditions
Aging Frailty
Interventions
BIOLOGICAL

Human umbilical cord mesenchymal stem cells（HUC-MSCs）

Human umbilical cord mesenchymal stem cells（HUC-MSCs）

BIOLOGICAL

Placebo

Placebo

Trial Locations (1)

200120

Shanghai East Hospital, Shanghai Tongji University, Shanghai

All Listed Sponsors
lead

Shanghai East Hospital

OTHER

NCT04314011 - Clinical Study of Umbilical Cord Mesenchymal Stem Cells Infusion for Aging Frailty | Biotech Hunter | Biotech Hunter